Abstract:Endothelial progenitor cells(EPC) are bone marrow derived cells with the potential to differentiate into mature functional endothelial cells.Studies have shown that patients with coronary heart disease or heart failure may suffer from decreased amounts and impaired function of peripheral circulating EPC.Drug induced mobilization of EPC and normalization of EPC function may therefore improve the prognosis of certain cardiovascular diseases.This article reviews studies of the factors influencing EPC,and suggests roles it might play in invesgating potential drug targets.

Endothelial Progenitor Cells-Potential Targets of Drug Therapy